ישראל - עברית - Ministry of Health

bayer israel ltd - dexpanthenol - משחה - dexpanthenol 5 % - dexpanthenol - dexpanthenol - for the treatment of light skin wounds. prevention and treatment of chafed, cracked or split skin. dry skin. regular breast care in nursing mothers and treatment of sore or cracked nipples. infant care: prevention and treatment of nappy (diaper) rash.

ישראל - עברית - Ministry of Health

bayer israel ltd - chlorhexidine dihydrochloride; dexpanthenol - קרם - dexpanthenol 5 %; chlorhexidine dihydrochloride 0.5 % - chlorhexidine, combinations - chlorhexidine, combinations - antiseptic healing treatment of wounds of any kind with an infection risk : such as slight skin irritations, wounds, cuts, burns and skin inflammation.

ישראל - עברית - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole

ישראל - עברית - Ministry of Health

bayer israel ltd - clotrimazole - קרם - clotrimazole 1 %w/w - clotrimazole

ישראל - עברית - Ministry of Health

novartis israel ltd - capmatinib as dihydrochloride monohydrate - טבליות מצופות פילם - capmatinib as dihydrochloride monohydrate 150 mg - capmatinib

ישראל - עברית - Ministry of Health

novartis israel ltd - capmatinib as dihydrochloride monohydrate - טבליות מצופות פילם - capmatinib as dihydrochloride monohydrate 200 mg - capmatinib

ישראל - עברית - Ministry of Health

"סופלקס בע""מ " - כלל האוכלוסיה - תמיסה לטיפול בעדשות מגע

ישראל - עברית - Ministry of Health

medison pharma ltd - doxorubicin hydrochloride - אבקה, מפזר וממס להכנת תרכיז לפיזור באינפוזיה - doxorubicin hydrochloride 50 mg vials - doxorubicin - doxorubicin - myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 1 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 2 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.